Absolv
ACD/Absolv streamlines the calculation of Abraham solvation parameters and related properties from chemical structures, enhancing data management in process chemistry. It allows for batch processing with minimal user input and integrates seamlessly with corporate intranets or cloud services, making it an efficient choice for predicting solvation behavior in compounds.
Top Absolv Alternatives
StackScan
Curious about a website’s technology stack? Use StackScan to explore 50,000+ technologies across 450+ categories of stacks.
Chemical Computing Group
Offering advanced tools for 3D molecular visualization, Chemical Computing Group empowers researchers in structure-based and ligand-based design, antibody development, and virtual screening. Their innovative solutions, including MOEsaic and PSILO®, facilitate protein, DNA/RNA modeling, molecular simulations, and cheminformatics, enhancing discovery and analysis in medicinal chemistry and structural biology.
Katalyst D2D
Katalyst D2D is a cutting-edge drug discovery software that streamlines high-throughput experimentation through integrated automation for planning, executing, and analyzing experiments. It connects live analytical data, enabling swift decision-making. With advanced machine learning tools and seamless integration with laboratory systems, Katalyst D2D enhances efficiency and optimizes experimental designs, revolutionizing medicinal chemistry workflows.
Impurity Profiling Suite
The Impurity Profiling Suite efficiently predicts toxicological endpoints for impurities and degradants, ensuring compliance with ICH M7 guidelines. Developed in collaboration with the FDA, it assesses genotoxic and carcinogenic risks, supports regulatory submissions, and offers a user-friendly interface for analyzing and ranking results across numerous compounds.
ADME Suite
The ADME Suite is an advanced drug discovery software that streamlines the prediction of absorption, distribution, metabolism, and excretion (ADME) properties. It allows researchers to efficiently process chemistry data, screen numerous compounds, and optimize lead modifications, while integrating seamlessly with existing workflows to ensure product safety for human use.
Bruker Drug Discovery
In the realm of drug discovery, Bruker offers a suite of advanced analytical tools that facilitate the identification and optimization of promising drug candidates. Utilizing techniques such as NMR, mass spectrometry, and preclinical imaging, their solutions enable researchers to gain pivotal insights into protein-ligand interactions and ADME-Toxicity early in the development process.
NoviSight 3D
NoviSight 3D cell analysis software enhances research by delivering precise statistical data on spheroids and other three-dimensional structures in microplate experiments. It quantifies cell activity, enabling the identification of rare events and accurate cell counts. Featuring True 3D technology, it allows for in-depth morphological assessments and the measurement of key parameters, accelerating the discovery process.
AIDDISON
AIDDISON™ AI Drug Discovery software empowers medicinal chemists by offering an integrated platform for designing, optimizing, screening, and planning synthesis. Utilizing advanced AI/ML models trained on extensive proprietary data, it enables efficient virtual screening and supports innovative de novo design of small-molecule libraries for in-silico lead discovery and optimization.
LiveDesign
LiveDesign offers a flexible, cloud-native environment for discovery teams, facilitating small and large molecule research. It streamlines workflows through centralized access to experimental and in silico data, enabling collaborative decision-making. Users can integrate predictive modeling, crowdsource ideas, and track progress seamlessly, driving innovation in drug discovery and materials science.
AlphaFold
AlphaFold revolutionizes biological research by predicting protein structures with remarkable accuracy. Since its inception in 2020, it has unveiled over 200 million intricate 3D configurations, drastically reducing the time and cost associated with protein analysis. This innovation empowers scientists across various fields, accelerating discoveries that address critical medical and environmental challenges.
Schrödinger
Transforming drug discovery and materials research, Schrödinger's advanced molecular modeling platform leverages physics-driven computational solutions for predictive modeling and data analytics. Employed across diverse industries, from pharmaceuticals to aerospace, it facilitates rapid exploration of chemical spaces, optimizing workflows and enhancing collaboration to tackle critical research challenges effectively.
LigPlot+
LigPlot+ is an advanced tool for automatically creating 2D ligand-protein interaction diagrams, featuring an intuitive Java interface that supports on-screen editing through click-and-drag functionality. Enhancements include automatic superposition of similar complexes, highlighting conserved interactions, and an updated DIMPLOT for visualizing protein-protein or domain-domain interactions efficiently.
Phoenix PK/PD Platform
The Phoenix™ PK/PD Platform equips scientists with advanced tools for pharmacokinetic and pharmacodynamic modeling, facilitating robust analysis from preclinical to regulatory phases. With features like non-compartmental analysis, population modeling, and in vitro-in vivo correlation, it enhances decision-making, ensures regulatory compliance, and streamlines workflows across drug development stages.
BIOVIA Discovery Studio
BIOVIA Discovery Studio empowers researchers in the biopharmaceutical industry by integrating over three decades of peer-reviewed research with advanced in silico techniques. This software enables the modeling and simulation of molecular interactions, facilitating the design and optimization of biotherapeutics and small molecule drugs, from target identification to lead optimization.
SCIEX
This drug discovery software seamlessly integrates with high-performance LC-MS/MS systems, enhancing data acquisition and analysis for precise molecular detection. With tailored workflow modules, users can optimize quantitative and qualitative assessments, leading to faster, more reliable results. Its user-friendly interface simplifies daily operations and training, maximizing laboratory efficiency.
BioNeMo
BioNeMo is an advanced AI-powered drug discovery platform designed to streamline the entire pipeline, from target identification to lead optimization. It integrates multimodal generative AI with robust workflows for 3D protein structure prediction, docking, and virtual screening. Users can leverage pre-trained models and optimized microservices to accelerate research, enhance model performance, and reduce time-to-market for innovative therapeutics.
Company Information
- Company: ACD/Labs
- Country: Canada
Top Absolv Features
- Batch solvation parameter calculations
- Hydrogen bonding acidity analysis
- Hydrogen bonding basicity assessment
- Polarity determination tools
- Excessive molar refraction calculations
- Comprehensive data management
- Browser-based application access
- KNIME integration support
- Compatibility with Windows/Linux
- Graphical user interface
- Corporate intranet deployment
- Environmental chemistry applications
- Predictive physicochemical property modeling
- Literature reference access
- Minimal user intervention processing
- Expert systems integration
- Structure drawing capabilities
- Nomenclature support tools
- Educational resources and webinars
- Consultation and demo requests
